Anti-JMJD4 antibodies are used in the immunodetection of the protein jumonji domain containing 4. In humans, the canonical protein has a reported length of 463 amino acid residues and a mass of 52.5 kDa. Its subcellular localization is in the cytoplasm. Up to 2 different isoforms have been reported for this protein. JMJD4 is known to catalyze the 2-oxoglutarate and iron-dependent C4-lysyl hydroxylation of ETF1 at 'Lys-63' thereby promoting the translational termination efficiency of ETF1. Synonyms for this target antigen include 2-oxoglutarate- and Fe(II)-dependent oxygenase, C4 lysyl hydroxylase, jmjC domain-containing protein 4, jumonji domain-containing protein 4, and 2-oxoglutarate and iron-dependent oxygenase JMJD4. JMJD4 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Western Blot is the most common application for the JMJD4 antibodies listed below. ELISA and Immunohistochemistry are also common applications.